Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing

The National Institute of Allergy and Infectious Diseases (NIAID) Virology Quality Assurance (VQA) established a robust proficiency testing program for Sanger sequencing (SS)-based HIV-1 drug resistance (HIVDR) testing in 2001. While many of the lessons learned during the development of such program...

Descripció completa

Dades bibliogràfiques

Autors principals:	Cheryl Jennings, Neil T. Parkin, Daniel J. Zaccaro, Rupert Capina, Paul Sandstrom, Hezhao Ji, Donald J. Brambilla, James W. Bremer
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2020-12-01
Col·lecció:	Viruses
Matèries:	HIV-1 drug resistance next-generation sequencing external quality assurance Sanger sequencing
Accés en línia:	https://www.mdpi.com/1999-4915/12/12/1456
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!